Emerging specialty pharma company Orexo has announced a restructure to its leadership as it prepares for US commercialisation of its anti-opiod dependence drug Zubsolv and pain-killer for cancer sufferers, Abstral.
http://www.in-pharmatechnologist.com/Regulatory-Safety/People-on-the-move-Jobs-in-Pharma49?
http://www.in-pharmatechnologist.com/Regulatory-Safety/People-on-the-move-Jobs-in-Pharma49?
No comments:
Post a Comment